메뉴 건너뛰기




Volumn 30, Issue 5, 2007, Pages 1283-1285

Glycemic control and absenteeism among individuals with diabetes

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

EID: 34247599810     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-1657     Document Type: Article
Times cited : (18)

References (22)
  • 1
    • 0032334679 scopus 로고    scopus 로고
    • Health and labor market performance: The case of diabetes
    • Kahn ME: Health and labor market performance: the case of diabetes. Journal of Labor Economics 16:878-899, 1998
    • (1998) Journal of Labor Economics , vol.16 , pp. 878-899
    • Kahn, M.E.1
  • 2
    • 0035132222 scopus 로고    scopus 로고
    • Impact of diabetes on employment and income in Manitoba, Canada
    • Kraut A, Walld R, Tate R, Mustard C: Impact of diabetes on employment and income in Manitoba, Canada. Diabetes Care 24:64-68, 2001
    • (2001) Diabetes Care , vol.24 , pp. 64-68
    • Kraut, A.1    Walld, R.2    Tate, R.3    Mustard, C.4
  • 4
    • 0035141050 scopus 로고    scopus 로고
    • Productivity losses associated with diabetes in the U.S
    • Ng YC, Jacobs P, Johnson JA: Productivity losses associated with diabetes in the U.S. Diabetes Care 24:257-261, 2001
    • (2001) Diabetes Care , vol.24 , pp. 257-261
    • YC, N.1    Jacobs, P.2    Johnson, J.A.3
  • 5
    • 0036302013 scopus 로고    scopus 로고
    • The impact of diabetes on adult employment and earnings of Mexican Americans: Findings from a community based study
    • Bastida E, Pagan JA: The impact of diabetes on adult employment and earnings of Mexican Americans: findings from a community based study. Health Econ 11:403-413, 2002
    • (2002) Health Econ , vol.11 , pp. 403-413
    • Bastida, E.1    Pagan, J.A.2
  • 6
    • 19444363530 scopus 로고    scopus 로고
    • The impact of diabetes on employment: Genetic IVs in a bivariate probit
    • Brown HS 3rd, Pagon JA, Bastida E: The impact of diabetes on employment: genetic IVs in a bivariate probit. Health Econ 14:537-544, 2005
    • (2005) Health Econ , vol.14 , pp. 537-544
    • Brown 3rd, H.S.1    Pagon, J.A.2    Bastida, E.3
  • 7
    • 10044280419 scopus 로고    scopus 로고
    • The impact of diabetes on workforce participation: Results from a national household sample
    • Vijan S, Hayward RA, Langa KM: The impact of diabetes on workforce participation: results from a national household sample. Health Serv Res 39:1653-1669, 2004
    • (2004) Health Serv Res , vol.39 , pp. 1653-1669
    • Vijan, S.1    Hayward, R.A.2    Langa, K.M.3
  • 9
    • 32144448938 scopus 로고    scopus 로고
    • Standards of medical care in diabetes: 2006 (Position Statement)
    • American Diabetes Association
    • American Diabetes Association: Standards of medical care in diabetes: 2006 (Position Statement). Diabetes Care 29 (Suppl. 1):S4-S42, 2006
    • (2006) Diabetes Care , vol.29 , Issue.SUPPL. 1
  • 10
    • 0037387712 scopus 로고    scopus 로고
    • Treatment of hypertension in type 2 diabetes mellitus: Blood pressure goals, choice of agents, and setting priorities in diabetes care
    • Vijan S, Hayward RA: Treatment of hypertension in type 2 diabetes mellitus: blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 138:593-602, 2003
    • (2003) Ann Intern Med , vol.138 , pp. 593-602
    • Vijan, S.1    Hayward, R.A.2
  • 11
    • 7344263454 scopus 로고    scopus 로고
    • Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
    • UK Prospective Diabetes Study Group
    • UK Prospective Diabetes Study Group: Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 317:720-726, 1998
    • (1998) BMJ , vol.317 , pp. 720-726
  • 12
    • 0037092913 scopus 로고    scopus 로고
    • Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes
    • CDC
    • CDC: Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA 287:2542-2551, 2002
    • (2002) JAMA , vol.287 , pp. 2542-2551
  • 13
    • 4444382862 scopus 로고    scopus 로고
    • Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: Background paper for the American College of Physicians
    • Vijan S, Hayward RA: Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians. Ann Intern Med 140:650-658, 2004
    • (2004) Ann Intern Med , vol.140 , pp. 650-658
    • Vijan, S.1    Hayward, R.A.2
  • 14
    • 0033836167 scopus 로고    scopus 로고
    • Cost-effectiveness of treating hyperlipidemia in the presence of diabetes: Who should be treated?
    • Grover SA, Coupal L, Zowall H, Dorais M: Cost-effectiveness of treating hyperlipidemia in the presence of diabetes: who should be treated? Circulation 102:722-727, 2000
    • (2000) Circulation , vol.102 , pp. 722-727
    • Grover, S.A.1    Coupal, L.2    Zowall, H.3    Dorais, M.4
  • 15
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
    • UK Prospective Diabetes Study (UKPDS) Group
    • UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
    • (1998) Lancet , vol.352 , pp. 837-853
  • 16
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group
    • The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 17
    • 0032483719 scopus 로고    scopus 로고
    • Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial
    • Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled, double-blind trial. JAMA 280:1490-1496, 1998
    • (1998) JAMA , vol.280 , pp. 1490-1496
    • Testa, M.A.1    Simonson, D.C.2
  • 19
    • 0000270827 scopus 로고    scopus 로고
    • Race and gender in the labor market
    • Ashenfelter O, Card D, Eds. Amsterdam, Elsevier Science
    • Altonji JG, Blank R: Race and gender in the labor market. In Handbook of Labor Economics. Ashenfelter O, Card D, Eds. Amsterdam, Elsevier Science, 1999, p. 3144-3259
    • (1999) Handbook of Labor Economics , pp. 3144-3259
    • Altonji, J.G.1    Blank, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.